XOLACTA
Live / Allowed — Notice of allowance issued (as of 25 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98414541
- Mark type
- Stylized text
- Filed
- 21 Feb 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- TARA PELAN
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; drug delivery systems in the nature of exosomes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosome-based drug delivery systems for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes for medical purposes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes for therapeutic purposes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; biological preparations comprising exosomes for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; synthetic peptides for the treatment of internal diseases and wounds for use in treating cardiovascular, neurological, and inflammatory diseases and disorders, cancer, chronic wounds, tissue injuries, and radiation sickness, and as a radioprotectant against radiotherapy; exosomes loaded with synthetic peptides for the treatment of internal diseases and wounds caused by cardiovascular, neurological, and inflammatory diseases and disorders, cancer, radiation sickness, and radiotherapy
Owner
- The Tiny Cargo Company, Roanoke, VA, US
- The Tiny Cargo Company, Roanoke, VA, US
Prosecution history
- 25 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Oct 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 20 Oct 2025 — OPPOSITION TERMINATED NO. 999999
- 20 Oct 2025 — OPPOSITION DISMISSED NO. 999999
- 09 Jun 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 09 Jun 2025 — OPPOSITION INSTITUTED NO. 999999
- 09 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2024 — EXAMINER'S AMENDMENT ENTERED